ReviewDiseases (Basel, Switzerland)2017

Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?

Theodosios D Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.